Shepard Kirk V. 4
4 · PDS Biotechnology Corp · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Shepard Kirk V.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
[F1]2026-01-12+300,000→ 300,000 totalExercise: $0.98Exp: 2036-01-12→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Signature
/s/ Kirk V. Shepard|2026-03-03